$CUTR
CUTERA INC

2016 Q3 Form 10-Q Financial Statement

#000143774916041264 Filed on November 07, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q3
Revenue $30.28M $23.09M
YoY Change 31.17% 23.28%
Cost Of Revenue $12.54M $9.594M
YoY Change 30.69% 20.91%
Gross Profit $17.74M $13.49M
YoY Change 31.52% 25.02%
Gross Profit Margin 58.59% 58.44%
Selling, General & Admin $13.29M $11.73M
YoY Change 13.33% 9.58%
% of Gross Profit 74.9% 86.92%
Research & Development $2.914M $2.748M
YoY Change 6.04% 4.57%
% of Gross Profit 16.42% 20.37%
Depreciation & Amortization $250.0K $290.0K
YoY Change -13.79% -12.12%
% of Gross Profit 1.41% 2.15%
Operating Expenses $16.20M $14.48M
YoY Change 11.94% 8.59%
Operating Profit $1.539M -$984.0K
YoY Change -256.4% -61.24%
Interest Expense $80.00K $70.00K
YoY Change 14.29%
% of Operating Profit 5.2%
Other Income/Expense, Net $166.0K $84.00K
YoY Change 97.62%
Pretax Income $1.705M -$900.0K
YoY Change -289.44% -64.55%
Income Tax $61.00K $57.00K
% Of Pretax Income 3.58%
Net Earnings $1.644M -$957.0K
YoY Change -271.79% -63.69%
Net Earnings / Revenue 5.43% -4.15%
Basic Earnings Per Share $0.12 -$0.07
Diluted Earnings Per Share $0.12 -$0.07
COMMON SHARES
Basic Shares Outstanding 13.16M 13.83M
Diluted Shares Outstanding 13.54M 13.83M

Balance Sheet

Concept 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.40M $47.70M
YoY Change -2.73% -40.89%
Cash & Equivalents $11.28M $10.06M
Short-Term Investments $35.10M $37.70M
Other Short-Term Assets $2.500M $2.100M
YoY Change 19.05% 10.53%
Inventory $16.48M $13.48M
Prepaid Expenses
Receivables $11.68M $9.013M
Other Receivables $0.00 $0.00
Total Short-Term Assets $77.05M $72.28M
YoY Change 6.59% -29.48%
LONG-TERM ASSETS
Property, Plant & Equipment $1.720M $1.386M
YoY Change 24.1% 6.62%
Goodwill $1.339M $1.339M
YoY Change 0.0%
Intangibles $16.00K $227.0K
YoY Change -92.95%
Long-Term Investments
YoY Change
Other Assets $444.0K $392.0K
YoY Change 13.27% 30.67%
Total Long-Term Assets $3.929M $3.635M
YoY Change 8.09% -17.39%
TOTAL ASSETS
Total Short-Term Assets $77.05M $72.28M
Total Long-Term Assets $3.929M $3.635M
Total Assets $80.98M $75.92M
YoY Change 6.67% -28.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.283M $2.659M
YoY Change 23.47% -1.52%
Accrued Expenses $14.79M $12.23M
YoY Change 20.86% 35.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.38M $23.36M
YoY Change 12.92% 14.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $597.0K $538.0K
YoY Change 10.97% -90.39%
Total Long-Term Liabilities $597.0K $538.0K
YoY Change 10.97% -90.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.38M $23.36M
Total Long-Term Liabilities $597.0K $538.0K
Total Liabilities $28.57M $26.58M
YoY Change 7.47% 1.46%
SHAREHOLDERS EQUITY
Retained Earnings -$31.31M -$31.72M
YoY Change -1.31%
Common Stock $83.77M $81.06M
YoY Change 3.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.41M $49.33M
YoY Change
Total Liabilities & Shareholders Equity $80.98M $75.92M
YoY Change 6.67% -28.98%

Cashflow Statement

Concept 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income $1.644M -$957.0K
YoY Change -271.79% -63.69%
Depreciation, Depletion And Amortization $250.0K $290.0K
YoY Change -13.79% -12.12%
Cash From Operating Activities $1.600M -$620.0K
YoY Change -358.06% -50.79%
INVESTING ACTIVITIES
Capital Expenditures -$170.0K -$20.00K
YoY Change 750.0% -81.82%
Acquisitions
YoY Change
Other Investing Activities $720.0K $16.94M
YoY Change -95.75% 1288.52%
Cash From Investing Activities $550.0K $16.92M
YoY Change -96.75% 1410.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.710M -17.88M
YoY Change -109.56% -2983.87%
NET CHANGE
Cash From Operating Activities 1.600M -620.0K
Cash From Investing Activities 550.0K 16.92M
Cash From Financing Activities 1.710M -17.88M
Net Change In Cash 3.860M -1.580M
YoY Change -344.3% -429.17%
FREE CASH FLOW
Cash From Operating Activities $1.600M -$620.0K
Capital Expenditures -$170.0K -$20.00K
Free Cash Flow $1.770M -$600.0K
YoY Change -395.0% -47.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
143000
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5589000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4096000
CY2016Q3 us-gaap Inventory Net
InventoryNet
16478000
CY2015Q4 us-gaap Inventory Net
InventoryNet
12078000
CY2016Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10889000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7982000
CY2016Q3 us-gaap Liabilities
Liabilities
28568000
CY2015Q4 us-gaap Liabilities
Liabilities
27484000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80977000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
14475000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77518000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
26381000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24431000
CY2016Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
35108000
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
37539000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1106000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-27205000
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
166000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
527000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
188000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
16204000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2050000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
23944000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
32705000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2749000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5248000
us-gaap Net Income Loss
NetIncomeLoss
-1636000
us-gaap Net Income Loss
NetIncomeLoss
-6490000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
1644000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-957000
us-gaap Operating Expenses
OperatingExpenses
48270000
us-gaap Operating Expenses
OperatingExpenses
42904000
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3086000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2354000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
444000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
384000
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-24000
CY2015Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-19000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1539000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-984000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2048000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6518000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
56000
CY2015Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-23000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
55000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-5000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
1000
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-25000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
6000
CY2016Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-9000
CY2015Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-6000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16000
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000
CY2016Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
1000
CY2015Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
4000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
1000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
584000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-45000
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
597000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
20000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
138000
CY2016Q3 cutr Available For Sale Securities Debt Maturities Year Two Through Three Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughThreeFairValue
6694000
CY2016Q3 cutr Cash And Cash Equivalents And Marketable Investments Amortized Cost
CashAndCashEquivalentsAndMarketableInvestmentsAmortizedCost
46367000
CY2015Q4 cutr Cash And Cash Equivalents And Marketable Investments Amortized Cost
CashAndCashEquivalentsAndMarketableInvestmentsAmortizedCost
48446000
CY2016Q3 cutr Cash And Cash Equivalents And Marketable Investments Fair Market Value
CashAndCashEquivalentsAndMarketableInvestmentsFairMarketValue
46383000
CY2015Q4 cutr Cash And Cash Equivalents And Marketable Investments Fair Market Value
CashAndCashEquivalentsAndMarketableInvestmentsFairMarketValue
48407000
CY2016Q3 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
1700000
CY2015Q3 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
1500000
cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
4900000
cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
4600000
CY2015 cutr Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
213000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4873000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
36616000
cutr Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1
cutr Maximum Maturity Period Of Investments
MaximumMaturityPeriodOfInvestments
P1Y
cutr Noncash Repurchase Of Common Stock Not Settled
NoncashRepurchaseOfCommonStockNotSettled
cutr Noncash Repurchase Of Common Stock Not Settled
NoncashRepurchaseOfCommonStockNotSettled
604000
cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
493858
cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
925675
cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
141500
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3283000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1959000
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11680000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11669000
CY2016Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
164000
CY2015Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
182000
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14786000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13834000
CY2016Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
7865000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
7726000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-54000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-89000
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
83758000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79782000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
570000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1044000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2652000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2987000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2178000
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2664000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2511000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3161000
CY2016Q3 us-gaap Assets
Assets
80977000
CY2015Q4 us-gaap Assets
Assets
77518000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
77048000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
73829000
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
35108000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
37539000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
21000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
46000
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
35092000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
37578000
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
28414000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
580000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
51000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11275000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10868000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9803000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10055000
CY2016Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
11275000
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10868000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
407000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
252000
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13388830
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13388830
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12980807
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12980807
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
13000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1628000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-974000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1601000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6495000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
10160000
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7625000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
26804000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
22555000
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
12538000
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
9594000
us-gaap Cost Of Revenue
CostOfRevenue
33959000
us-gaap Cost Of Revenue
CostOfRevenue
28333000
CY2016Q3 us-gaap Cost Of Services
CostOfServices
2378000
CY2015Q3 us-gaap Cost Of Services
CostOfServices
1969000
us-gaap Cost Of Services
CostOfServices
7155000
us-gaap Cost Of Services
CostOfServices
5778000
CY2016Q2 us-gaap Deferred Revenue
DeferredRevenue
10223000
CY2015Q2 us-gaap Deferred Revenue
DeferredRevenue
11546000
CY2015Q4 us-gaap Deferred Revenue
DeferredRevenue
10469000
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
12949000
CY2016Q3 us-gaap Deferred Revenue
DeferredRevenue
9293000
CY2015Q3 us-gaap Deferred Revenue
DeferredRevenue
10678000
CY2016Q3 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
2517000
CY2015Q3 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
2331000
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
8825000
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
7383000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8312000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8638000
CY2016Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1426000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2287000
CY2016Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3447000
CY2015Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3199000
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
10001000
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
9654000
CY2016Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
410000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
350000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
733000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
912000
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2716000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2937000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9933000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8940000
CY2016Q3 us-gaap Goodwill
Goodwill
1339000
CY2015Q4 us-gaap Goodwill
Goodwill
1339000
CY2016Q3 us-gaap Gross Profit
GrossProfit
17743000
CY2015Q3 us-gaap Gross Profit
GrossProfit
13491000
us-gaap Gross Profit
GrossProfit
46222000
us-gaap Gross Profit
GrossProfit
36386000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1705000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
690000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-247000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-217000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-900000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1521000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6330000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
115000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1324000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-424000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
61000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2124000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-18000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
42000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
886000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
544000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1187000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2279000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4400000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2491000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
60000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
31000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1675000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6197000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9554000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
20135000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
29024000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
6153000
CY2016Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4788000
CY2015Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4288000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
14887000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
311000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
703000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2507000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
19271000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2016Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2100000
CY2015Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1819000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1720000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1473000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
218000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
143000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2914000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2748000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8335000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7921000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31308000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29672000
CY2016Q3 us-gaap Revenues
Revenues
30281000
CY2015Q3 us-gaap Revenues
Revenues
23085000
us-gaap Revenues
Revenues
80181000
us-gaap Revenues
Revenues
64719000
CY2016Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1735000
CY2015Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1935000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
25493000
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
18797000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
65903000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
51542000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
14278000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
13177000
CY2016Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10574000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8790000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30002000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26043000
us-gaap Share Based Compensation
ShareBasedCompensation
2652000
us-gaap Share Based Compensation
ShareBasedCompensation
2987000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1263425
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
812481
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
122373
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.19
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
141500
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2148797
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1461402
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.31
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.29
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.28
CY2016Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2000000
CY2015Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1254000
CY2015Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1819000
CY2014Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1167000
CY2016Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2100000
CY2015Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1397000
CY2016Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1102000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
52409000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
50034000
CY2015Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
979000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3353000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2444000
CY2016Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1202000
CY2015Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1122000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3634000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2674000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
706522
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of interim Condensed Consolidated Financial Statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported and disclosed in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates these estimates, including those related to revenue elements, warranty obligations, sales commissions, accounts receivable and sales allowances, provision for excess and obsolete inventories, fair values of marketable investments, fair values of acquired intangible assets, useful lives of intangible assets and property and equipment, fair values of performance stock units and options to purchase the Company&#x2019;s stock, recoverability of deferred tax assets, legal matters and claims, and effective income tax rates, among others. Management bases these estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</div></div></div></div></div></div></div>
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13544000
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13827000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13102000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14290000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13163000
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13827000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13102000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14290000

Files In Submission

Name View Source Status
0001437749-16-041264-index-headers.html Edgar Link pending
0001437749-16-041264-index.html Edgar Link pending
0001437749-16-041264.txt Edgar Link pending
0001437749-16-041264-xbrl.zip Edgar Link pending
cutr-20160930.xml Edgar Link completed
cutr-20160930.xsd Edgar Link pending
cutr-20160930_cal.xml Edgar Link unprocessable
cutr-20160930_def.xml Edgar Link unprocessable
cutr-20160930_lab.xml Edgar Link unprocessable
cutr-20160930_pre.xml Edgar Link unprocessable
cutr20160818_10q.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending